Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis

AP Sunjaya, SM Allida, GL Di Tanna… - Journal of Asthma, 2022 - Taylor & Francis
Objective As COVID-19 spreads across the world, there are concerns that people with
asthma are at a higher risk of acquiring the disease, or of poorer outcomes. This systematic …

Diagnosing COVID‐19 in the emergency department: a sco** review of clinical examinations, laboratory tests, imaging accuracy, and biases

CR Carpenter, PA Mudd, CP West… - Academic …, 2020 - Wiley Online Library
Objective Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) emerged as a
global pandemic in early 2020 with rapidly evolving approaches to diagnosing the clinical …

[HTML][HTML] Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel

ER Adams, M Ainsworth, R Anand… - Wellcome Open …, 2020 - ncbi.nlm.nih.gov
Background: The COVID-19 pandemic caused> 1 million infections during January-March
2020. There is an urgent need for reliable antibody detection approaches to support …

[HTML][HTML] Biomarkers of COVID-19 and technologies to combat SARS-CoV-2

L Zhang, H Guo - Advances in Biomarker Sciences and Technology, 2020 - Elsevier
Due to the unprecedented public health crisis caused by COVID-19, our first contribution to
the newly launching journal, Advances in Biomarker Sciences and Technology, has abruptly …

The main molecular and serological methods for diagnosing COVID-19: an overview based on the literature

BAS Machado, KVS Hodel, VG Barbosa-Junior… - Viruses, 2020 - mdpi.com
Diagnostic tests have been considered as the main alternative for the control of coronavirus
disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS …

[HTML][HTML] SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons

N Wellinghausen, D Plonné, M Voss, R Ivanova… - Journal of Clinical …, 2020 - Elsevier
Commercially available immunoassays have been developed for sensitive and specific
detection of antibodies against SARS-CoV-2. While a fast and reliable IgG response has …

[HTML][HTML] Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients

C Serre-Miranda, C Nobrega, S Roque… - International Journal of …, 2021 - Elsevier
Background Commercial availability of serological tests to evaluate immunoglobulins (Ig)
targeting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has grown …

Polymorphism and selection pressure of SARS-CoV-2 vaccine and diagnostic antigens: implications for immune evasion and serologic diagnostic performance

E Dumonteil, C Herrera - Pathogens, 2020 - mdpi.com
The ongoing SARS-CoV-2 pandemic has triggered multiple efforts for serological tests and
vaccine development. Most of these tests and vaccines are based on the Spike glycoprotein …

Evaluation of commercially available immuno‐magnetic agglutination in comparison to enzyme‐linked immunosorbent assays for rapid point‐of‐care diagnostics of …

ME Moeller, J Fock, P Pah, ADLC Veras… - Journal of Medical …, 2021 - Wiley Online Library
Abstract Introduction Coronavirus disease 2019 (COVID‐19) is caused by Severe acute
respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Fast, accurate, and simple blood …

Reinfection with SARS-CoV-2 and waning humoral immunity: a case report

JD Goldman, K Wang, K Röltgen, SCA Nielsen… - Vaccines, 2022 - mdpi.com
Recovery from COVID-19 is associated with production of anti-SARS-CoV-2 antibodies, but
it is uncertain whether these confer immunity. We describe viral RNA shedding duration in …